Effects of changes in intracellular action potential on potentials recorded by single-fiber, macro, and belly-tendon electrodes

Muscle and Nerve

Volumn 37, Issue 6, 2008, Pages 700-712

  Arabadzhiev, Todor I ^a   Dimitrov, George V ^a   Chakarov, Vichren E ^a   Dimitrov, Alexander G ^a   Dimitrova, Nonna A ^a  

^a CENTRE OF BIOMEDICAL ENGINEERING   (Bulgaria)

Author keywords

Belly tendon detection; Calcium; Macro EMG; Muscular dystrophy; Myopathy; Neuropathy; SFAP

Indexed keywords

CALCIUM ION;

ACTION POTENTIAL; ARTICLE; CALCULATION; DEPOLARIZATION; ELECTRODE; ELECTROMYOGRAM; ELECTROMYOGRAPHY; MATHEMATICAL ANALYSIS; MOTOR UNIT POTENTIAL; MUSCLE CELL; PRIORITY JOURNAL; SIGNAL DETECTION; SIMULATION; TENDON;

ACTION POTENTIALS; ALGORITHMS; CALCIUM; ELECTRODES; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; EXTRACELLULAR SPACE; HUMANS; MOTOR ENDPLATE; MOTOR NEURONS; MUSCLE FIBERS; SPINOCEREBELLAR DEGENERATIONS; TENDONS;

EID: 44949224453     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21024     Document Type: Article

References (72)

1. Arabadzhiev T, Dimitrov G, Chakarov V, Dimitrov A, Dimitrova N. Changes in intracellular action potential profile affect parameters used in turns/amplitude analysis. Muscle Nerve (in press).
2. Balog EM, Thompson LV, Fitts RH. Role of sarcolemma action potentials and excitability in muscle fatigue. J Appl Physiol 1994;76:2157-2162.
3. Bertorini TE, Bhattacharya SK, Palmieri GM, Chesney CM, Pifer D, Baker B. Muscle calcium and magnesium content in Duchenne muscular dystrophy. Neurology 1982;32:1088-1092.
4. Bertorini TE, Palmieri GM, Griffin J, Igarashi M, Hinton A, Karas JG. Effect of dantrolene in Duchenne muscular dystrophy. Muscle Nerve 1991;14:503-507.
5. Bodensteiner JB, Engel AG. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies. Neurology 1978;28:439-446.
6. 2+] in the development of low frequency fatigue in mouse single muscle fibres. J Physiol 1996;491:813-824.
7. Dimitrov GV. Changes in the extracellular potentials produced by unmyelinated nerve fibre resulting from alterations in the propagation velocity or the duration of the action potential. Electromyogr Clin Neurophysiol 1987;27:243-249.
8. Dimitrov GV, Dimitrova NA. Influence of the afterpotentials on the shape and magnitude of the extracellular potentials generated under activation of excitable fibres. Electromyogr Clin Neurophysiol 1979;19:249-267.
9. Dimitrov GV, Dimitrova NA. Extracellular potentials produced by a transition between an inactive and active regions of an excitable fibre. Electromyogr Clin Neurophysiol 1989;29:265-271.
10. Dimitrov GV, Dimitrova NA. Precise and fast calculation of the motor unit potentials detected by a point and rectangular plate electrode. Med Eng Phys 1998;20:374-381.
11. Dimitrova N. Influence of the length of the depolarized zone on the extracellular potential field of a single unmyelinated nerve fibre. Electromyogr Clin Neurophysiol 1973;13:547-558.
12. Dimitrova N. Model of the extracellular potential field of a single striated muscle fibre. Electromyogr Clin Neurophysiol 1974;14:53-66.
13. Dimitrova NA, Dimitrov GV. Amplitude-related characteristics of motor unit and M-wave potentials during fatigue. A simulation study using literature data on intracellular potential changes found in vitro. J Electromyogr Kinesiol 2002;12:339-349.
14. Dimitrova NA, Dimitrov GV. Interpretation of EMG changes with fatigue: facts, pitfalls, and fallacies. J Electromyogr Kinesiol 2003;13:13-36.
15. Dimitrova NA, Dimitrov GV. Electromyography (EMG) modeling. In: Metin A, editor. Wiley encyclopedia of biomedical engineering. Hoboken, NJ: John Wiley & Sons; 2006.
16. Dimitrova NA, Hogrel JY, Arabadzhiev TI, Dimitrov GV. Estimate of M-wave changes in human biceps brachii during continuous stimulation. J Electromyogr Kinesiol 2005;15:341-348.
17. Emery AE, Burt D. Intracellular calcium and pathogenesis and antenatal diagnosis of Duchenne muscular dystrophy. Br Med J 1980;280:355-357.
18. Fawcett PR, Kennett RP, Schofield IS, Johnson MA. A neurophysiological investigation of the facio-scapulo-humeral (FSH) syndrome. J Neurol Sci 1990;98.
19. Fenn WO. Loss of potassium in voluntary contraction. Am J Physiol 1937;120:675-680.
20. Finsterer J, Fuglsang-Frederiksen A. Macro-EMG in mitochondriopathy. Clin Neurophysiol 1999;110:1466-1470.
21. Finsterer J, Fuglsang-Frederiksen A. Concentric-needle versus macro EMG. II. Detection of neuromuscular disorders. Clin Neurophysiol 2001;112:853-860.
22. Gath I, Stålberg E. Frequency and time domain characteristics of single muscle fibre action potentials. ElectroencephalogrClín Neurophysiol 1975;39:371-376.
23. Gath I, Stålberg E. The calculated radial decline of the extracellular action potential compared with in situ measurements in the human brachial biceps. Electroencephalogr Clin Neurophysiol 1978;44:547-552.
24. Gath I, Stålberg E. Measurements of the uptake area of small-size electromyographic electrodes. IEEE Trans Biomed Eng 1979;26:374-376.
25. Gillis JM. Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse. J Muscle Res Cell Motil 1999;20:605-625.
26. 2+ in muscle cell damage. Ann NY Acad Sci 2005;1066:166-180.
27. 2+ uptake in rat skeletal muscle. Am J Physiol 1999;276:R331-339.
28. 2+ influx and skeletal muscle cell damage. Acta Physiol Scand 2001;171:327-334.
29. Gydikov A, Kosarov D. Volume conduction of the potentials from separate motor units in human muscle. Electromyogr Clin Neurophysiol 1972;12:127-147.
30. Håkansson CH. Action potentials recorded intra- and extracellularly from the isolated frog muscle fibre in Ringer's solution and in air. Acta Physiol Scand 1957;39:291-312.
31. 2+ indicator FFP-18. Cell Calcium 2006;40:299-307.
32. Hanson J, Persson A. Changes in the action potential and contraction of isolated frog muscle after repetitive stimulation. Acta Physiol Scand 1971;81:340-348.
33. Hilton-Brown P, Stålberg E. Motor unit size in muscular dystrophy, a macro EMG and scanning EMG study. J Neurol Neurosurg Psychiatry 1983;46:996-1005.
34. Howell JN, Snowdowne KW. Inhibition of tetanus tension by elevated extracellular calcium concentration. Am J Physiol 1981;240:C193-200.
35. Imbert N, Cognard C, Duport G, Guillou C, Raymond G. Abnormal calcium homeostasis in Duchenne muscular dystrophy myotubes contracting in vitro. Cell Calcium 1995;18:177-186.
36. Imbert N, Vandebrouck C, Constantin B, Duport G, Guillou C, Cognard C, et al. Hypoosmotic shocks induce elevation of resting calcium level in Duchenne muscular dystrophy myotubes contracting in vitro. Neuromuscul Disord 1996;6:351-360.
37. Ishiko N, Sato M. The effect of calcium ions on electrical properties of striated muscle fibres. Jpn J Physiol 1957;7:51-63.
38. 2+] abolishes excitation-contraction coupling in skeletal muscle fibres of rat and toad. J Physiol 1995;489:349-362.
39. Lännergren J, Westerblad H. Action potential fatigue in single skeletal muscle fibres of Xenopus. Acta Physiol Scand 1987;129:311-318.
40. Lateva ZC, McGill KC. The physiological origin of the slow afterwave in muscle action potentials. Electroencephalogr Clin Neurophysiol 1998;109:462-469.
41. Ludin HP. Action potentials of normal and dystrophic human muscle fibers. In: Desmedt JE, editor. New development in electromyography and clinical neurophysiology. Basel: Karger; 1973. p. 400-406.
42. Lüttgau HC. The effect of metabolic inhibitors on the fatigue of the action potential in single muscle fibres. J Physiol 1965; 178:45-67.
43. Maunder-Sewry CA, Gorodetsky R, Yarom R, Dubowitz V. Element analysis of skeletal muscle in Duchenne muscular dystrophy using x-ray fluorescence spectrometry. Muscle Nerve 1980;3:502-508.
44. Metzger JM, Fitts RH. Fatigue from high- and low-frequency muscle stimulation: role of sarcolemma action potentials. Exp Neurol 1986;93:320-333.
45. Nandedkar SD. Models and simulations in electromyography. Muscle Nerve 2002;27(suppl 11):S46-54.
46. Nandedkar SD, Barkhaus PE, Sanders DB, Stålberg EV. Analysis of amplitude and area of concentric needle EMG motor unit action potentials. Electroencephalogr Clin Neurophysiol 1988;69:561-567.
47. Nandedkar SD, Sanders DB. Simulation of myopathic motor unit action potentials. Muscle Nerve 1989;12:197-202.
48. Nandedkar SD, Sanders DB, Stålberg EV. Simulation and analysis of the electromyographic interference pattern in normal muscle. Part I: Turns and amplitude measurements. Muscle Nerve 1986;9:423-430.
49. Nandedkar SD, Sigi JC, Kim YI, Stålberg EV. Radial decline of the extracellular action potential. Med Biol Eng Comput 1984;22:564-568.
50. Nandedkar SD, Sanders DB, Stålberg EV. Automatic analysis of the electromyographic interference pattern. Part II: Findings in control subjects and in some neuromuscular diseases. Muscle Nerve 1986;9:491-500.
51. Nandedkar S, Stålberg E. Simulation of macro EMG motor unit potentials. Electroencephalogr Clin Neurophysiol 1983;56:52-62.
52. Nandedkar SD, Stålberg E. Simulation of single muscle fibre action potentials. Med Biol Eng Comput 1983;21:158-165.
53. Obere MA, Engel WK. Ultrastructural localization of calcium in normal and abnormal skeletal muscle. Lab Invest 1977;36:566-577.
54. Plonsey R, Heppner DB. Considerations of quasi-stationarity in electrophysiological systems. Bull Math Biophys 1967;29:657-664.
55. Radicheva N, Gerilovsky L, Gydikov A. Changes in the muscle fibre extracellular action potentials in long-lasting (fatiguing) activity. Eur J Appl Physiol Occup Physiol 1986;55:545-552.
56. Rodríguez Falces J, Malanda Trigueros A, Gila Useros L, Rodríguez Carreño I, Navallas Irujo J. Modeling fibrillation potentials - a new analytical description for the muscle intracellular action potential. IEEE Trans Biomed Eng 2006;53:581-592.
57. Shahani BT, Fang J, Dhand UK. A new approach to motor unit estimation with surface EMG triggered averaging technique. Muscle Nerve 1995;18:1088-1092.
58. Stålberg E. Propagation velocity in human muscle fibers in situ. Acta Physiol Scand 1966;287(suppl):1-112.
59. Stålberg E. Invited review. Electrodiagnostic assessment and monitoring of motor unit changes in disease. Muscle Nerve 1991;14:293-303.
60. Stålberg E, Andreassen S, Falck B, Lang H, Rosenfalck A, Trojaborg W. Quantitative analysis of individual motor unit potentials: a proposition for standardized terminology and criteria for measurement. J Clin Neurophysiol 1986;3:313-348.
61. Stålberg E, Falck B. The role of electromyography in neurology. Electroencephalogr Clin Neurophysiol 1997;103:579-598.
62. Stålberg E, Trontelj JV. Single fiber electromyography. Old Woking, UK: Mirvalle Press; 1979.
63. Stålberg E, Trontelj J. Clinical neurophysiology: the motor unit in myopathy. In: Rowland LP, editor. Handbook of clinical neurology. Vol. 18. New York: Elsevier; 1992. p. 49-84.
64. Torbergsen T, Stålberg E, Aasly J, Lindal S. Myopathy in Marinesco-Sjogren syndrome: an electrophysiological study. Acta Neurol Scand 1991;84:132-138.
65. Torbergsen T, Stålberg E, Bless JK. Nerve-muscle involvement in a large family with mitochondrial cytopathy: electrophysiological studies. Muscle Nerve 1991;14:35-41.
66. Vandebrouck C, Duport G, Raymond G, Cognard C. Hypotonic medium increases calcium permeant channels activity in human normal and dystrophic myotubes. Neurosci Lett 2002;323:239-243.
67. Vandebrouck C, Martin D, Colson-Van Schoor M, Debaix H, Gailly P. Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers. J Cell Biol 2002;158:1089-1096.
68. Westerblad H, Allen DG. Changes of myoplasmic calcium concentration during fatigue in single mouse muscle fibers. J Gen Physiol 1991;98:615-635.
69. 2+ in long-lasting fatigue of skeletal muscle. Eur J Appl Physiol 2000;83:166-174.
70. Westerblad H, Duty S, Allen DG. Intracellular calcium concentration during low-frequency fatigue in isolated single fibers of mouse skeletal muscle. J Appl Physiol 1993;75:382-388.
71. 2+. J Appl Physiol 1997;83:444-450.
72. Yeung EW, Allen DG. Stretch-activated channels in stretch-induced muscle damage: role in muscular dystrophy. Clin Exp Pharmacol Physiol 2004;31:551-556.